Rx/Reimbursement Adult Incontinence in Serbia

  • ID: 4517590
  • Report
  • Region: Serbia
  • 13 pages
  • Euromonitor International
1 of 3
There were no changes in the way Rx/reimbursement adult incontinence products are distributed amongst Serbian consumers in 2017. According to Serbian Law on Health Insurance, patients that have the right to get 60 units of incontinence products are children aged 3-18 with mental problems that cause incontinence problems; children aged 3-18 with neurogenically induced incontinence; and patients with paraplegia, quadriplegia, muscle dystrophia, multiple sclerosis and cerebral paralysis that have i...

The publisher's Rx/Reimbursement adult incontinence in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 3
Rx/Reimbursement Adult Incontinence In Russia

Headlines

Prospects

Rx State Support Continues Growing
Further Economic Uncertainty May Hamper More Significant Rx/Reimbursement

Category Data
Table 1 Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp 2012-2017
Table 2 Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp Growth 2012-2017
Table 3 Forecast Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp 2017-2022
Table 4 Forecast Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp Growth 2017-2022
Executive Summary
Structural Factors Continue Affecting Sales
Price Sensitivity And State Aid Affect Category Performance
Global Heavyweights Hold Share
Retail Consolidation In Offline Channel Continues
Moderate Performance, Not A New Boom, Anticipated

Market Indicators
Table 5 Birth Rates 2012-2017
Table 6 Infant Population 2012-2017
Table 7 Female Population By Age 2012-2017
Table 8 Total Population By Age 2012-2017
Table 9 Households 2012-2017
Table 10 Forecast Infant Population 2017-2022
Table 11 Forecast Female Population By Age 2017-2022
Table 12 Forecast Total Population By Age 2017-2022
Table 13 Forecast Households 2017-2022

Market Data
Table 14 Retail Sales Of Tissue And Hygiene By Category: Value 2012-2017
Table 15 Retail Sales Of Tissue And Hygiene By Category: % Value Growth 2012-2017
Table 16 Nbo Company Shares Of Retail Tissue And Hygiene: % Value 2013-2017
Table 17 Lbn Brand Shares Of Retail Tissue And Hygiene: % Value 2014-2017
Table 18 Penetration Of Private Label In Retail Tissue And Hygiene By Category: % Value 2012-2017
Table 19 Distribution Of Retail Tissue And Hygiene By Format: % Value 2012-2017
Table 20 Distribution Of Retail Tissue And Hygiene By Format And Category: % Value 2017
Table 21 Forecast Retail Sales Of Tissue And Hygiene By Category: Value 2017-2022
Table 22 Forecast Retail Sales Of Tissue And Hygiene By Category: % Value Growth 2017-2022
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll